4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000950170-25-018125
Options or other derivatives
- Chief Executive Officer acquired 960,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MacBeath Gavin Chief Executive Officer | 2024-01-12 | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | D: show line 1 in the form | ||
| MacBeath Gavin Chief Executive Officer | 2025-01-03 | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…